Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 29, 2001

View Archived Issues

Efexor XR, a long-term alternative to benzodiazepines in treating anxiety

Avax granted licensing option for SCID gene therapy technology

Phase II trial of MG-98 in renal cell carcinoma begins

Dexmethylphenidate hydrochloride receives FDA approvable letter for ADHD

Novartis files FDA application for Zometa as treatment for bone metastases

Neurocrine Biosciences expands clinical development efforts during Q2

A promising scaffold for bioartificial liver development

Crucell establishes human antibody agreement with Centocor for treatment of cancer

Medennium's SmartPlug receives E.U. clearance for treatment of dry eyes

SS Pharmaceutical discovers antifungal compounds with improved solubility

Continued progress in clinical programs reported at Guilford

DepoMed highlights recent product developments

Neuron-selective Ca channel blocker discovered at Eisai

Altana reports decisive progress in development of roflumilast and ciclesonide

Selective glucocorticoid receptor modulators described by Pfizer at ACS meeting

UCB's Xyzal receives pan-European approval

GSK presents new PPARgamma agonists during the ongoing ACS meeting

Mixed 5-HT2A and TP-receptor antagonists added at Servier pipeline reported at ACS

Dual PPARgamma/alpha agonists identified at Kotobuki

GSK claims new adenosine A1 agonist formulations for the treatment of pain

AMPA receptor antagonists presented by Kyorin

Natural antibacterial and antitumor agent isolated by Kyowa Hakko

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...